Quanome Technologies is a holding company whose sole revenue-generating business is Hupan Pharmaceutical, a pharmaceutical distributor in China. Hupan Pharmaceutical operates in the midstream of the healthcare supply chain, sourcing products directly from manufacturers and reselling them at a markup to hospitals, other distributors, and healthcare providers. Its core product categories include infusion products, foods for special medical purposes, and specialty pharmaceuticals, which it distributes primarily through third-party sales agents. Alongside this distribution business, Quanome is pursuing two early-stage, pre-revenue technology initiatives. Through its subsidiary XDT Infrastructure, Quanome is developing an AI compute infrastructure business to provide customers with high-performance GPU server capacity and managed inference services via an infrastructure-as-a-service model. Through Quantum Nexus, Quanome is evaluating opportunities in quantum computing and advanced simulation for applications in therapeutics, materials science, energy, and cybersecurity.